Machine learning models identify molecules active against the Ebola virus in vitro [version 3; referees: 2 approved]
The search for small molecule inhibitors of Ebola virus (EBOV) has led to several high throughput screens over the past 3 years. These have identified a range of FDA-approved active pharmaceutical ingredients (APIs) with anti-EBOV activity in vitro and several of which are also active in a mouse inf...
Main Authors: | Sean Ekins, Joel S. Freundlich, Alex M. Clark, Manu Anantpadma, Robert A. Davey, Peter Madrid |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-01-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/4-1091/v3 |
Similar Items
-
Machine learning models identify molecules active against the Ebola virus in vitro [version 1; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2015-10-01) -
Machine learning models identify molecules active against the Ebola virus in vitro [version 2; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2016-01-01) -
Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library [version 1; referees: 2 approved]
by: Bruno S. Pascoalino, et al.
Published: (2016-10-01) -
Enterovirus D68 in Viet Nam (2009-2015) [version 1; referees: 2 approved, 1 approved with reservations]
by: Nguyen Thi Han Ny, et al.
Published: (2017-06-01) -
In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus [version 2; referees: 2 approved]
by: Jaspreet Jain, et al.
Published: (2017-12-01)